AGADA Biosciences

About:

AGADA Biosciences provides orphan drug development services and drug testing for neuromuscular disorders.

Top Investors: Innovacorp, Atlantic Canada Opportunities Agency

Description:

AGADA Biosciences is an accelerated drug development form. They offer to develop standard operating procedures. They provide advice on human trial design, regulatory writing, biomarker method development, qualification, and validation.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Halifax, Nova Scotia, Canada

Founded Date:

2013-01-01

Contact Email:

amullen(AT)agadabio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-01-24

IPO Status:

Private

Industries: